Status:
COMPLETED
Improving Tobacco Treatment Rates for Cancer Patients Who Smoke
Lead Sponsor:
Abramson Cancer Center at Penn Medicine
Collaborating Sponsors:
University of Pennsylvania
Conditions:
Cancer
Tobacco Use
Eligibility:
All Genders
Phase:
NA
Brief Summary
The research objective is to identify a simple, pragmatic, innovative way of enhancing Tobacco Use Treatment (TUT) rates within oncology. To investigate this possibility, the investigators propose met...
Detailed Description
To reduce all-cause and cancer-specific mortality, the 2014 Surgeon General's Report emphasized the importance of effective tobacco use treatment (TUT) in cancer care. Unfortunately, up to 50% of canc...
Eligibility Criteria
Inclusion
- Currently in active practice within Medical and Radiation Oncology divisions of ACC,
- Prescribing authority in Pennsylvania (i.e. physician, nurse practitioner, physician assistant),
- Nonsmoker,
- Has cared for at least one patient with tobacco use disorder in the 30 days prior to recruitment,
- English speaking, and
- Willing to provide informed consent to participate.
Exclusion
- Unwillingness to prescribe varenicline, or
- Unwillingness to assign varenicline management to TUT Service providers.
Key Trial Info
Start Date :
June 28 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 24 2024
Estimated Enrollment :
685 Patients enrolled
Trial Details
Trial ID
NCT04738643
Start Date
June 28 2022
End Date
January 24 2024
Last Update
May 8 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Penn Presbyterian Medical Center
Philadelphia, Pennsylvania, United States, 19104
2
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104